Patritumab deruxtecan, with or without letrozole, showed similar efficacy to chemotherapy in high-risk HR-positive, HER2-negative breast cancer, with lower severe side effects. The SOLTI VALENTINE ...
Greater reduction seen in proliferation when megestrol was added to letrozole in postmenopausal women. HealthDay News — Low-dose megestrol added to letrozole is associated with a greater reduction in ...
Letrozole is prescribed for certain types of breast cancer. It's a generic medication and is available as the brand-name drug Femara. It comes as an oral tablet. The cost of letrozole can vary, but ...
Tamoxifen has been approved by the FDA for adjuvant hormone treatment of premenopausal or postmenopausal women as well as men with ER-positive early-stage breast cancer, and anastrozole, letrozole, ...
Six-month PFS exceeded 50% overall, and median PFS was 9.5 months, indicating clinically meaningful disease stabilization in advanced/recurrent endometrioid endometrial cancer. Chemotherapy-naïve ...
Impact of Propofol Exposure on Neurocognitive Outcomes in Children With High-Risk B ALL: A Children's Oncology Group Study In AMEERA-5 (ClinicalTrials.gov identifier: NCT04478266), a double-blind, ...
VIKTORIA-2 Trial Evolves to Evaluate Gedatolisib in Endocrine-Sensitive and -Resistant Breast Cancer
Significant protocol amendments have been made to the ongoing phase 3 VIKTORIA-2 clinical trial (NCT06757634).The study, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results